Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001
Business Overview: The Company operates 157 outpatient physical and occupational therapy clinics across 31 states, providing post-operative care and treatment for orthopedic and sports-related injuries. As of the reporting date, the average age of clinics was 4.02 years. The Company also manages six third-party facilities.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2001 | Nine Months Ended Sep 30, 2001 | Dec 31, 2000 (Balance Sheet) |
|---|---|---|---|
| Net Revenues | $20,582 | $59,378 | -- |
| Net Income | $1,825 | $5,124 | -- |
| Operating Income | $4,335 | $12,479 | -- |
| Cash and Equivalents | -- | -- | $9,785 |
| Net Cash from Operations (9mo) | -- | $12,139 | -- |
| Total Debt (Notes Payable + Convertible) | -- | -- | $3,658 |
| Current Ratio | -- | -- | 6.12 to 1.00 |
| Debt-to-Equity Ratio | -- | -- | 0.15 to 1.00 |
Earnings Per Share (Diluted): $0.14 for the three months ended Sep 30, 2001; $0.40 for the nine months ended Sep 30, 2001.
Material Changes vs. Prior Period
- Revenue Growth: Net patient revenues increased 29% ($4.5M) for the quarter and 28% ($12.7M) for the nine months compared to the prior year periods. This was driven by a 25% increase in patient visits and the addition of 30 new clinics.
- Profitability: Net income increased 71% for the quarter and 91% for the nine months year-over-year. Operating margins improved as clinic operating costs as a percentage of revenue decreased to 68% from 71% (quarterly) and 72% (nine-month).
- Interest Expense: Interest expense dropped significantly (70% for the quarter, 64% for the nine months) due to the conversion of approximately $5.05 million of convertible subordinated debt into common stock.
- Liquidity: Cash and cash equivalents grew from $2.1 million at year-end 2000 to $9.8 million at September 30, 2001, primarily due to strong operating cash flows and proceeds from stock option exercises.
Guidance, Outlook, and Risks
- Outlook: Management expects existing funds and operating cash flows to be sufficient to meet needs through 2002. The goal for 2001 is to open between 30 and 35 clinics. New clinics are expected to have lower initial margins due to start-up costs but will favorably impact results over the subsequent two to three years.
- Acquisitions: On September 30, 2001, the Company purchased a 35% minority interest in a Michigan partnership owning nine clinics for approximately $2.1 million (stock and note). Additional contingent consideration of up to $1.425 million may be paid over five years based on earnings performance.
- Convertible Debt: The Company retains $3.0 million in Series C Convertible Subordinated Notes due June 30, 2004. The fair value of these notes was estimated at $13.95 million based on the stock price as of November 9, 2001.
- Accounting Changes: The Company adopted SFAS 133 (Derivatives) with no material effect. Future adoption of SFAS 142 (Goodwill) is expected to eliminate approximately $70,000 in annual amortization expense, though impairment testing requirements remain.
- Risks: Forward-looking statements are subject to risks including regulatory changes, competition, and the ability to identify suitable locations and partners for new clinics.
Investor Verification Checklist
- Debt Conversion Impact: Verify the dilution effect of the $5.05 million in convertible debt converted to equity and the resulting interest savings of ~$400,000 annually.
- New Clinic Performance: Monitor the ramp-up period for the 30 new clinics opened since late 2000 to ensure they meet projected revenue and margin targets.
- Contingent Acquisition Costs: Track the earnings performance of the acquired Michigan clinics to determine if the additional $1.425 million in contingent consideration will be triggered.
- Minority Interest Distributions: Review cash flow statements for distributions to minority investors in subsidiary partnerships, which totaled $3.1 million for the nine-month period.
- Stock Splits: Confirm that all per-share data has been adjusted for the two-for-one split (Jan 2001) and three-for-two split (June 2001).